Could psilocybin from magic mushrooms be a future treatment for depression and addiction? Some researchers believe so.
Psychedelic substances such as LSD and psilocybin have been outlawed for decades, but there is growing international interest in their possible therapeutic benefits, especially in areas such as treating depression and addiction. Cliff Taylor looks at the evidence and finds local researchers keen to unlock the psychedelics’ potential
I don’t think it’s pie in the sky to prepare for the potential of using these substances in a therapeutic setting
It’s hard to believe these days
There are some important changes in the Privacy Act 2020 —such as mandatory notification of privacy breaches, additional restrictions on disclosing personal information offshore (including health information), additional criminal offences, compliance notices and enforceable access directions